Sign Up For Free
Looking at the state of the research
For the past 100 years, cannabis consumers, growers and advocates haven’t been alone in dealing with the ramifications of strict laws governing the cannabis plant, nearly the world over. The so called velvet handcuffs have also hindered researchers in the space, with many advances accomplished behind closed doors, or in laboratories where courageous researchers have pushed the boundaries of what the scientifically permissible, or then possible.
Famed Israeli scientist Raphael Mechoulam first synthetized THC in 1964, a breakthrough that piqued the interest of curious researchers. Since that work, more than 70 cannabinoids and hundreds of terpenes have been isolated from the cannabis plant. The list of various single-molecule products, containing only THC or CBD – or some concentration of the two – is extensive. The reason for this variety can be traced to the initial work of one Jewish scientist.1
The cannon of literary journals with cannabis at the topic is study has been growing exponentially as jurisdictions have moved to increasingly allow the use of medical cannabis. As the plant has found itself under more microscopes in recent years, advancements have been made across nearly every category of the industry. As just a few examples, research in the area has allowed for new delivery mechanisms, product innovations, and revolutionary work like isolating cannabis molecules to treat specific disorders.
In Canada, where cannabis is legal at the federal level, cannabis research has really started to come into fruition. In recent years, there has been an influx of academic institutions that are warmly welcoming state-of-the-art cannabis research into their laboratories. Students can also find cannabis schools in the U.S., where a number of reputable colleges offer training in everything from production to cannabis marketing.2
Much of the research on the cannabis plant now has everything to do with its cannabinoid and terpenoids. These molecules are often being isolated, or mixed, with the product being new cannabis-based drugs and delivery mechanisms. Cannabis patients have lately, as a result, had a host of new products made available to them. Where the research has been able to thrive, so to have patient access to efficient cannabis-based medicines been made more available.
While cannabis research has spent most of the past century in the shadows, recent legislative allowances have granted scientists unprecedented access to the plant. The result, it seems, is progress – new products, more innovation in the space and, certainly, hope even for the discovery of even more uses for cannabis plant.

  1. Cannabinoid pharmacology: the first 66 years. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1760722/
  2. Canadian schools set to capitalize on marijuana businesses. https://www.macleans.ca/education/canadian-schools-set-to-capitalize-on-marijuana-businesses/

This article is now marked as read.

Was this article helpful?

Review this article to help us continue creating and sharing relevant content.

Please note it may take up to two business days for reviews to be validated and published.


Review this article to help us continue creating and sharing relevant content.

Write Review

Would you like to
make this review public?

Please disable your ad blocker to avoid issues using social plugins on Cannvas.Me. Thanks.